Zobrazeno 1 - 10
of 1 212
pro vyhledávání: '"anti-PD 1"'
Autor:
Kranthi Kumar Chougoni
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 12 (2024)
Externí odkaz:
https://doaj.org/article/2ed45714f87b4cf9af2206c485eb8896
Autor:
Alexandra Serris, Amani Ouedrani, Fabrice Uhel, Marianne Gazzano, Vincent Bedarida, Claire Rouzaud, Marie-Elisabeth Bougnoux, Jean-Herlé Raphalen, Sylvain Poirée, Olivier Lambotte, Guillaume Martin-Blondel, Fanny Lanternier
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Invasive fungal diseases (IFD) still cause substantial morbidity and mortality, and new therapeutic approaches are urgently needed. Recent data suggest a benefit of checkpoint inhibitors (ICI). We report the case of a diabetic patient with refractory
Externí odkaz:
https://doaj.org/article/eb0e8f86a06e41dea4ad2fc22db87ede
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Primary pancreatic squamous cell carcinoma is sporadic. The diagnosis is usually made following surgery or needle biopsy and requires a thorough workup to exclude metastatic squamous cell carcinoma. Squamous cell carcinoma of the pancreas often has a
Externí odkaz:
https://doaj.org/article/e001a82425e54a9caec68fbb38f5e110
Autor:
Salem Chouaib, James Lorens
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Externí odkaz:
https://doaj.org/article/b5b9aa469ac7425d885362c848ca73b7
Autor:
Tianqi Chen, Erin X. Wei, Sean Singer, Nicole R. LeBoeuf, Anita Giobbie-Hurder, Arash Mostaghimi, Christine G. Lian, Caroline A. Nelson, Ashleigh Eberly Puleo
Publikováno v:
Journal of the American Academy of Dermatology. 87:e245-e248
Autor:
Bernardo Leon Rapoport
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Externí odkaz:
https://doaj.org/article/f37e0d948d4e4b31981eed541255b9dc
Autor:
Bingqing Hui, Lingyan Xu, Yanhong Gu, Xiaofeng Chen, Yuchen Yang, Yirui Zhou, Danping Wang, Xiaofei Li
Publikováno v:
Immunotherapy. 13:1317-1323
There exists a dilemma in the treatment of microsatellite stability (MSS) metastatic colorectal cancer (mCRC) owing to limited therapeutic options. Based on the promising results of the REGONIVO trial, combination of anti-PD-1 and regorafenib could b
Autor:
Victor E. Goldberg, Dariya T. Muravyova, Liubov A. Tashireva, Sergey V. Vtorushin, Natalya O. Popova, Vladimir M. Perelmuter
Publikováno v:
Biochemistry (Moscow). 86:1461-1468
Undoubtedly, one of the most promising approaches to the treatment of cancer is creation of the pathogenetically based therapeutic drugs. Researchers from all over the world are trying to answer the question on how to select a target that would be ef
Publikováno v:
Immunopharmacology and Immunotoxicology. 43:806-812
Using antibodies to block the programmed cell death 1 (PD-1)/programmed cell death-ligand 1 (PD-L1) pathway as an immunotherapy has achieved great success in the clinical treatment of various types...
Autor:
Xiaoyi Hu, Wen Kong, Haoran Zhang, Yiran Huang, Hao Zeng, Wen Cai, Jianming Guo, Wei Xue, Jin Zhang, Shuo Wang, Yichu Yuan, Yueming Wang, Ping Wang, Jiwei Huang, Qiang Wei
Publikováno v:
Cancer Communications, Vol 41, Iss 10, Pp 1071-1074 (2021)
Cancer Communications
Cancer Communications